143 related articles for article (PubMed ID: 37461232)
1. Keratin-Positive Giant Cell-Rich Tumor of Bone Harboring an
Patton A; Ilaslan H; Armstrong SM; Bakhshwin A; Cheng YW; Minhas F; Fritchie KJ
Int J Surg Pathol; 2024 May; 32(3):556-564. PubMed ID: 37461232
[TBL] [Abstract][Full Text] [Related]
2. Xanthogranulomatous epithelial tumors and keratin-positive giant cell-rich soft tissue tumors: two aspects of a single entity with frequent HMGA2-NCOR2 fusions.
Dehner CA; Baker JC; Bell R; Dickson BC; Schmidt RE; Demicco EG; Chrisinger JSA
Mod Pathol; 2022 Nov; 35(11):1656-1666. PubMed ID: 35690644
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (
Panagopoulos I; Andersen K; Gorunova L; Lund-Iversen M; Lobmaier I; Heim S
Cancer Genomics Proteomics; 2022; 19(2):163-177. PubMed ID: 35181586
[TBL] [Abstract][Full Text] [Related]
4. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors.
Agaimy A; Michal M; Stoehr R; Ferrazzi F; Fabian P; Michal M; Franchi A; Haller F; Folpe AL; Kösemehmetoğlu K
Mod Pathol; 2021 Aug; 34(8):1507-1520. PubMed ID: 33742141
[TBL] [Abstract][Full Text] [Related]
5. Keratin-positive giant cell-rich tumors of soft tissue with HMGA2::NCOR2 fusions.
Weigelt MA; Azzato EM; Habermehl GK; Billings SD; Ko JS; Fritchie KJ
J Cutan Pathol; 2023 Nov; 50(11):977-982. PubMed ID: 37496152
[TBL] [Abstract][Full Text] [Related]
6. Giant Cell Tumors With HMGA2::NCOR2 Fusion : Clinicopathologic, Molecular, and Epigenetic Study of a Distinct Entity.
Perret R; Malaka Z; Velasco V; Llamas-Gutierrez F; Ropars M; Linck PA; Hostein I; Azmani R; Valo I; Galmiche L; Moreau A; de Pinieux G; Michot A; Bochaton D; Coindre JM; Le Loarer F
Am J Surg Pathol; 2023 Jul; 47(7):801-811. PubMed ID: 37170907
[TBL] [Abstract][Full Text] [Related]
7. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
Shooshtarizadeh T; Rahimi M; Movahedinia S
Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
[TBL] [Abstract][Full Text] [Related]
8. Xanthogranulomatous Epithelial Tumors and Keratin-Positive Giant Cell Rich Tumors of Soft Tissue and Bone: Two Sides of the Same Coin.
Folpe AL
Surg Pathol Clin; 2024 Mar; 17(1):57-64. PubMed ID: 38278607
[TBL] [Abstract][Full Text] [Related]
9. [Giant cell-containing tumors of bone and differential diagnoses].
Heitkötter B; Hartmann W
Pathologe; 2022 May; 43(3):174-182. PubMed ID: 35467097
[TBL] [Abstract][Full Text] [Related]
10. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C
Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573
[TBL] [Abstract][Full Text] [Related]
11. Expression of H3.3 G34W Distinguishes Giant Cell Tumor of Bone From Its Major Giant Cell-containing Bone and Soft Tissue Mimics, in Particular Aneurysmal Bone Cyst and Giant Cell Tumor of Soft Tissue.
Creytens D
Appl Immunohistochem Mol Morphol; 2020; 28(5):e47-e48. PubMed ID: 29489506
[No Abstract] [Full Text] [Related]
12. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
Lee CH; Espinosa I; Jensen KC; Subramanian S; Zhu SX; Varma S; Montgomery KD; Nielsen TO; van de Rijn M; West RB
Mod Pathol; 2008 May; 21(5):531-9. PubMed ID: 18192965
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis of giant cell-rich lesions of bone].
Lang S
Pathologe; 2008 Nov; 29 Suppl 2():245-9. PubMed ID: 18836722
[TBL] [Abstract][Full Text] [Related]
14. CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor.
Dehner CA; Lo YC; Chopra S; Demicco EG; He K; Hirbe AC; Folpe AL; Chrisinger JSA
Hum Pathol; 2024 Jan; 143():1-4. PubMed ID: 37993023
[TBL] [Abstract][Full Text] [Related]
15. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
[TBL] [Abstract][Full Text] [Related]
16. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract][Full Text] [Related]
17. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
19. Giant cell-rich tumour with keratin expression and HMGA2::NCOR2 fusion presenting at a rare location, on the scalp of a 29-year-old male.
Wilsher MJ; Venus M; Fisher C
Pathology; 2024 Jun; 56(4):609-612. PubMed ID: 38341304
[No Abstract] [Full Text] [Related]
20. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group.
Sciot R; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Tallini G; Van den Berghe H; Vanni R; Willén H
Mod Pathol; 2000 Nov; 13(11):1206-10. PubMed ID: 11106078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
